Germany· DE-A57-b5d83ad0c00e4ebc
Imukin
A medicinal product containing recombinant human interferon gamma 1b, registered in Germany by Clinigen Healthcare B.V..
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Recombinant Human Interferon Gamma 1b
- Manufacturer
- Clinigen Healthcare B.V.
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Recombinant human interferon gamma 1b in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayImukinClinigen
- United StatesACTIMMUNEHorizon Therapeutics USA, Inc.
- FinlandImukinBoehringer Ingelheim International GmbH
- BelgiumImmukine 0,10 mgHorizon Pharma Ireland
- NetherlandsIMMUKINE, oplossing voor injectie 2 x 10.6 IE (0,1 mg)Clinigen Healthcare B.V.
- FranceIMUKIN 2 x 10<sup>6</sup> UI (0,1 mg), solution injectableCLINIGEN HEALTHCARE (PAYS BAS)
- SpainIMUKIN 100 microgramos SOLUCION INYECTABLEClinigen Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Spain · Imukin
- France · Imukin
- United Kingdom (Northern Ireland) · Immukin
- Italy · Imukin
- Netherlands · Immukine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ae13ab9-3be5-4392-bda4-9648139a7fde GET /v1/drugs/5ae13ab9-3be5-4392-bda4-9648139a7fde?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Recombinant Human Interferon Gamma 1b",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about recombinant human interferon gamma 1b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.